Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-25

FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application for Claritin-D 12 Hour, combining loratadine and pseudoephedrine sulfate. The approval expands the product labeling to p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin-D 12 Hour (loratadine and pseudoephedrine sulfate)

Snippet

SUPPL AP for CLARITIN-D 12 HOUR (LORATADINE AND PSEUDOEPHEDRINE SULFATE)